VivoSeq
Other

Euthyroid Sick Syndrome

1

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Euthyroid Sick Syndrome is an early-stage landscape with 1 program across 0 companies. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

Levothyroxine

Institut Jerome Lejeune

Analysis

Trial Status

1

clinical trials

Completed1 · 100%

Clinical Trials

Trial Activity

Levothyroxine for Children With Euthyroid Sick Syndrome
Completed·—·Phase 4·NCT01631305·80 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)